ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

KKR Buys Contract Research Firm PRA

by Ann M. Thayer
July 1, 2013 | APPEARED IN VOLUME 91, ISSUE 26

Genstar Capital is selling the contract research firm PRA International to an investment fund managed by Kohlberg Kravis Roberts & Co. Raleigh, N.C.-based PRA provides regulatory and clinical trial development services to pharmaceutical companies. It employs more than 5,300 people at 50 sites. In 2007, Genstar acquired then publicly traded PRA for $797 million and has since expanded the firm. Although the parties involved didn’t disclose a sales price, published reports put it at approximately $1.3 billion.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment